Plain-English translation of NCT04510740 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
JADE is a research study that gathers information about how patients with liver cancer (hepatocellular carcinoma or cholangiocarcinoma) are treated and how they respond to treatment over time. Rather than testing a new medication, this study watches and records the treatments that patients receive through their regular medical care—such as surgery, radiation, chemotherapy, or other therapies—and follows their health outcomes and quality of life for up to three years.
Doctors want to better understand which treatment combinations work best for different liver cancer patients and how these treatments affect daily life. By collecting this information from many patients across Germany, researchers can identify patterns in care and improve how they treat liver cancer in the future.
You likely qualify if…
You likely don't qualify if…
You will be followed for up to three years as part of your regular cancer care. Your doctors will record information about your treatments (surgery, radiation, chemotherapy, or other therapies), how you respond to them, and your quality of life during this time. If you participate in the quality-of-life portion, you may answer surveys about how you're feeling and functioning. Most of the information comes from your existing medical records and routine visits—you won't need to do anything extra beyond your normal cancer care appointments.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Germany
Sponsor
iOMEDICO AG
Enrollment target
~1,000 participants
Started
August 2020
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
iOMEDICO AG
Leipzig
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.